NMBU Banner

             Dr. David Feifel's Publications

                              Profile   |   Research   |   Publications


Shilling P.D., Melendez G., Priebe K., Richelson E., Feifel D.  Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an a1 Agonist. Psychopharmacology (Berl), Sep;175(3):353-9, 2004.

Feifel D., Melendez, G. and Shilling P.  Reversal of sensorimontor gating deficits in brattleboro rats by acute administration of clozapine and neurotensin agonist, but not haloperidol: a potential predictive model for novel antipsychotic effects. Neuropsychopharmacology, Apr 29(4):731-8, 2004. 

Wigal S., Swanson J.M., Feifel D., Sangal, R.B., Elia, J., Casat, C.D., Zeldis J.B. and Conners C.K.  A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention deficit hyperactivity disorder. Journal of the American Association of Adolescent and Child Psychiatry, Nov;43(11):1406-14, 2004.

Perry W., Minassian A. and Feifel D. Prepulse inhibition in patients with non-psychotic major depressive disorder. Journal of Affective Disorders, Aug;81(2):179-84, 2004.

Feifel D., Shilling P.D., Kuczenski R. and Segal D.S.  Altered extracellular dopamine concentration in the brains of  cholecystokinin-A receptor deficient rats. Neuroscience Letters, Sep 18;348(3):147-150, 2003.

Shilling P.D., Richelson E. and Feifel D.  The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition.  Behavioral Brain Research, 143:7-14, 2003.

Feifel D., Mendelez G. and Shilling P.D. A systemically administered neurotensin agonist blocks disruption of prepulse inhibition produced by a serotonin-2A agonist
. Neuropsychopharmacology, 28:651-653, 2003.

Shilling P.D. and Feifel D.  SR146131, a cholecystokinin: a receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI. Psychopharmacology, 164:285-293, 2002.

Perry W., Feifel D., Minassian A., Bhattacharjie I. and Braff D.L.  Information processing deficits in acutely psychotic schizophrenia patients medicated and unmedicated at the time of admission. American Journal of Psychiatry, Aug;159(8):1375-81, 2002.

Feifel D, Priebe K, Johnstone-Miller E, Morgan CJ.  Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning. Psychopharmacology (Berl). Jul;162(2):138-46, 2002.

Shilling P.D. and Feifel D.  Decreased haloperidol-induced potentiation of zif268 mRNA expression in the nucleus accumbens shell and the dorsal lateral striatum of rats lacking cholecystokinin-A receptors. Synapse. Feb;43(2):134-8. 2002.

Feifel D. and Priebe K. Vasopressin deficient rats exhibit sensorimotor gating deficits that are revised by subchronic haloperidol.  Biological Psychiatry, 50:425-433, 2001.

Perry W., Minassian A., Feifel D. and Braff D.L.  Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biological Psychiatry, 50:418-424, 2001.

Feifel D., Priebe K. and Shilling P.D. Startle and sensorimotor gating in rats lacking CCK-A receptors. Neuropsychopharmacology, 24:06, 2001.

Feifel D. Rationale and guidelines for the treatment of acute psychosis. Journal of Clinical Psychiatry, (Invited),  61(Suppl 14):27-31, 2000.

Shilling P.D., Feifel D. and Kelsoe J.R. Amphetamine-induced zif268  mRNA expression in the medial posterior nucleus accumbens of CCK-A receptor mutant rats. Neuroscience Letters, 281:17-20, 2000.

Feifel D. and Reza T.  Effects of neurotensin administered into the ventral tegmental area on prepulse inhibition of startle response.  Behavioral Brain Research, 106(1-2):189-93, 1999.

Feifel D. and Priebe K. The effects of subchronic haloperidol on intact and dizocilpine-disrupted sensorimotor gating.  Psychopharmacology, 146(2):175-9, 1999.

Feifel D.  Individual differences in prepulse inhibition of startle as a measure of intrinsic dopamine function.  Behavioral Neuroscience, 113(5):1020-9, 1999.

Feifel D., Moutier C. and Swerdlow N.R.  Attitudes toward psychiatry as a prospective career among students entering medical school.  American Journal of Psychiatry, 156(9):1397-402, 1999.

Feifel D. and Reza T. Oxytocin modulates psychotomimetic-induced sensorimotor gating deficits. Psychopharmacology, 141(1):93-98, 1999.

Feifel D., Reza T.L., Wustrow D. and Davis D.M.  Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist. Journal of Psychopharmacology Experimental Therapeutics, 288:710-713, 1999.

Feifel D.  Neurotransmitters And Neuromodulators In Frontal-Subcortical Circuits. The Human Frontal Lobes: Function and Disorders Eds. Miller B.L., Cummings J.L. Guilford Press, 174-186, 1999.

Feifel D., Reza  T.L. and Robeck S.L. Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis, Neuropsychopharmacology, 20(2):141-149, 1999.

Feifel D., Granholm E., Reza T., Perry W., Sarkin A. and Sprock J.  Contextual effects in the ability of ADHD adults to process visual stimuli. Biological Psychiatry, 43:49S (167), 1998.

Feifel D., Reza, T. L. and Robeck S.L. Prodopamine effect of intra-accumbens neurotensin on sensorimotor gating deficits. Peptides, 18:1457-1460, 1997.

Feifel D. and Swerdlow N.R.  Injections of CCK into the nucleus accumbens potentiate apomorhine-induced disruption of prepulse inhibition. Neuroscience Letters, 229:5-8, 1997.

Feifel D. and Minor L.K. Cysteamine blocks amphetamine-induced deficits in sensorimotor gating. Pharmacology, Biochemistry and Behavior, 58:689-693, 1997.

Feifel, D., Minor L.K., Delawa S. and Swerdlow N.R. The effects of intra-accumbens 
neurotensin on sensorimotor gating, Brain Research, 760:80 -84, 1997.

Feifel D. and Young C. Iron overload in an outpatient psychiatric clinic, Journal of Clinical Psychiatry, 58(2):74-78, 1997. 

Feifel D. Attention deficit disorder in adults. Postgraduate  Medicine, 100(3):207-218, 1996.

Feifel D. Parallels of  psychoanalytic theory and quantum mechanics (letter). Harvard Review of Psychiatry, 4:58, 1996.

Dickinson P.R., Feifel D. and Vaccarino F.J.  Blockade of endogenous GRF at dark-onset selectively suppresses protein intake. Peptides, 16(1):7-9, 1995.

Coscina D.V., Feifel D., Nobrega J.N. and Currie P.J.  Intraventricular but not intra-PVN metergoline elicits feeding in satiated rats. American Journal of Physiology, 266:R1562-7, 1994.

Feifel D. and Vaccarino F.J.  Growth hormone regulatory peptides  (GHRH  and Somatostatin) and Feeding: a model for the integration of central and peripheral function. Neuroscience and Biobehavioral Reviews, 18:421-33, 1994.

Feifel D., Vaccarino, F.J., Vale W. and Rivier J.  Evidence for a common neural mechanism mediating growth hormone-releasing factor-induced and somatostatin-induced feeding. Neuroendocrinology, 57:299-305, 1993.

Vaccarino F.J., Feifel D., Vale W. and  Rivier J.  Antagonism of central growth hormone-releasing factor activity selectively attenuates dark-onset feeding in rats. The Journal of Neuroscience, 11(12)3924-3927, 1991.

Feifel D. and Vaccarino F.J.   Central somatostatin: a re-examination of its effects on feeding. Brain Research, 535:189-194, 1990.

Feifel D. and Vaccarino F.J.   Central injections of growth hormone-releasing factor increase operant responding for food reward.  Progress in Neuropsychopharmacology and Biological Psychiatry, 525:189-194, 1990.

Feifel D., Vaccarino F.J., Vale W. and Rivier J.  Feeding effects of growth hormone-releasing factor in rats are photoperiod sensitive. Behavioral Neuroscience, 103:824-830, 1989.

Vaccarino F.R., Feifel D., Vale W., Rivier J. and  Koob G.  Centrally administered hypothalamic growth hormone-releasing factor stimulates food intake in free-feeding rats.  Peptides, 9(Suppl 1): 35-38, 1988.

Back to Top